## Individual study details

### Table S1: Neutralizing Sensitivity of Variants of Concern to Convalescent Plasma and Plasma from Vaccinated Persons

[table]
table_plasma_variant
[/table]

**Footnote:**

"*": The study is using authentic virus assay.

#### Addtional data

Original data from these studies are aggregated results (mean value or median value) rather than individual result.

[table]
table_plasma_variant_aggre
[/table]

### Table S2: Neutralizing Sensitivity of Variants of Concern to Monoclonal Antibodies

[table]
table_mab_variant
[/table]


### Table S3: Neutralizing Sensitivity of Spike Mutations to Convalescent Plasma and Plasma from Vaccinated Persons

[table]
table_plasma_muts
[/table]

**Footnote:**

"*": The study is using authentic virus assay.

#### Addtional data

Original data from these studies are aggregated results (mean value or median value) rather than individual result.

[table]
table_plasma_muts_aggre
[/table]

### Table S4: Neutralizing Sensitivity of Spike Mutations to Monoclonal Antibodies

[table]
table_mab_muts
[/table]
